Skip to content
The ACTC-DS repository is under review for potential modification in compliance with Administration directives.
Home
About Us
Alzheimer’s in Down Syndrome
Trials
Sites
News
Contact Us
Submit Proposal
A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression Disorder
Written by
in
Publication
←
Public and participant involvement as a pathway to inclusive dementia research
Relationship of cholinergic basal forebrain atrophy with the time course of Alzheimer’s disease pathology and cognitive decline in adults with Down syndrome: a longitudinal cohort study
→
More posts
